Client 1st Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$443K Buy
1,743
+199
+13% +$46.4K 0.12% 85
2026
Q1
$377K Sell
1,544
-104
-6% -$24.2K 0.11% 87
2025
Q4
$341K Buy
+1,648
New +$326K 0.11% 94

Other funds holding JNJ

Client 1st Advisory Group's JNJ Position: Q2 2026 in Review

Client 1st Advisory Group increased its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, buying an estimated $46.4K and bringing the position to 1,743 shares worth $443K. The position accounts for 0.12% of the portfolio, ranked #85.

Client 1st Advisory Group first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 1,173 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Client 1st Advisory Group held 1,743 shares of Johnson & Johnson worth $443K as of Q2 2026.
  • Client 1st Advisory Group bought 199 Johnson & Johnson shares in Q2 2026, an estimated $46.4K.
  • Johnson & Johnson made up 0.12% of Client 1st Advisory Group's portfolio in Q2 2026, its #85 holding.
  • Client 1st Advisory Group first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • 1,173 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Client 1st Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.